Van lent Pharma
ActiveSummary
Van lent Pharma has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €82,552 and a net result of €80,052. Equity is growing by about 11% per year across the filed financial years. Its solvency ranks better than 86% of 9,629 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Group and network
Connections & network
The board mandates are listed below; here you explore them as a network.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Board mandates elsewhere
1 board mandateBoard mandates of this companythis company sits on their board1